Stay updated on Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.

Latest updates to the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page
- Check7 days agoChange DetectedAdded NIH-required analyses for adverse events by sex and by race for mothers and infants, and updated timeframes (e.g., From birth through Week 50 postpartum) and measure descriptions to reflect these analyses.SummaryDifference1%

- Check14 days agoChange Detected- Page revision updated from v3.6.3 to v3.6.4, indicating a newer build of the page.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.3, indicating a newer version of the page or its documentation. This change does not alter the study content presented on the page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now indicates recruitment has ended and includes new user guidance sections for reading the study record and joining the study; header formatting for Interventions was adjusted and the page revision updated to v3.6.0.SummaryDifference0.3%

- Check64 days agoChange DetectedThe page displays Revision: v3.5.5 instead of v3.5.4, indicating a minor maintenance update to the page.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, signaling a new release of the page’s content or underlying system. This appears to be a behind-the-scenes update rather than a modification to visible study information.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.